A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
Clinical trial NCT05620407 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05620407
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2026-10-19
- Enrollment
- 513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.